000 | 01876 a2200505 4500 | ||
---|---|---|---|
005 | 20250516190013.0 | ||
264 | 0 | _c20140321 | |
008 | 201403s 0 0 eng d | ||
022 | _a1527-7755 | ||
024 | 7 |
_a10.1200/JCO.2013.53.2549 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPiccart-Gebhart, Martine J | |
245 | 0 | 0 |
_aThe 41st David A. Karnofsky Memorial Award Lecture: Academic research worldwide--quo vadis? _h[electronic resource] |
260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cFeb 2014 |
||
300 |
_a347-54 p. _bdigital |
||
500 | _aPublication Type: Lecture; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAntineoplastic Agents |
650 | 0 | 4 | _aAwards and Prizes |
650 | 0 | 4 | _aBiomarkers, Tumor |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aClinical Trials as Topic _xeconomics |
650 | 0 | 4 |
_aCommerce _xtrends |
650 | 0 | 4 |
_aDrug Industry _xtrends |
650 | 0 | 4 | _aDrugs, Investigational |
650 | 0 | 4 | _aEurope |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInformation Dissemination |
650 | 0 | 4 | _aInternational Cooperation |
650 | 0 | 4 | _aKarnofsky Performance Status |
650 | 0 | 4 | _aLeadership |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMulticenter Studies as Topic _xeconomics |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aPatient-Centered Care _xstandards |
650 | 0 | 4 |
_aPublic Health _xtrends |
650 | 0 | 4 |
_aResearch Design _xtrends |
650 | 0 | 4 |
_aResearch Personnel _xstandards |
650 | 0 | 4 |
_aResearch Support as Topic _xeconomics |
650 | 0 | 4 | _aUnited Kingdom |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aUniversities |
773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 32 _gno. 4 _gp. 347-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2013.53.2549 _zAvailable from publisher's website |
999 |
_c23394428 _d23394428 |